文献速递骨显像与常规 SPECT

长期抗骨吸收治疗患者的纤维性发育不良显示99mTc-FAPI摄取

Fibrous Dysplasia With 99m Tc-FAPI Uptake in a Patient Under Long-term Antiresorptive Therapy.
PubMed 文献 · Clin Nucl Med · 2026-07-01

本文报道一例40岁女性长病程颅面纤维性发育不良,累及右上颌骨、眶腔及额顶骨,曾行上颌骨部分减容术和眶减压术,目前接受长期抗骨吸收治疗。99mTc-MDP骨显像显示多处成骨活性增高,99mTc-FAPI SPECT/CT显示颅面及其他病灶局灶性摄取,提示成纤维细胞增殖活跃。这是首例报道纤维性发育不良中99mTc-FAPI摄取,提示其可用于评估纤维性骨病灶。

要点

  • 纤维性发育不良在长期抗骨吸收治疗下仍可显示99mTc-FAPI局灶性摄取。
  • 99mTc-FAPI摄取提示成纤维细胞增殖活跃,有助于评估纤维性骨病灶。
  • 这是首例报道纤维性发育不良中99mTc-FAPI摄取的病例。

核心结论

  • 99mTc-FAPI SPECT/CT在纤维性发育不良病灶中显示局灶性摄取,提示成纤维细胞增殖活跃,为首例报道。

研究设计与样本

  • 个案报道:一例40岁女性长病程颅面纤维性发育不良,累及右上颌骨、眶腔及额顶骨。

主要发现

  • 99mTc-MDP骨显像显示多处成骨活性增高灶。
  • 99mTc-FAPI SPECT/CT显示颅面及其他病灶局灶性摄取,提示成纤维细胞增殖活跃。

临床怎么用

  • 99mTc-FAPI SPECT/CT可能用于评估纤维性骨病灶的成纤维细胞增殖活性。

局限性

  • 仅为一例个案报道,结论需更多病例验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report a rare case of a 40-year-old woman with longstanding craniofacial fibrous dysplasia involving the right maxilla, orbital cavity, and fronto-parietal bones. The patient underwent partial maxillary debulking 7 years ago for cosmetic reasons and orbital decompression 3 years ago, and is currently on long-term antiresorptive therapy. Bone scintigraphy with 99mTc-MDP showed multiple sites of increased osteoblastic activity. 99mTc-FAPI SPECT/CT also revealed focal uptake in craniofacial and other lesions, indicating active fibroblast proliferation. This is the first reported case of 99mTc-FAPI uptake in fibrous dysplasia, suggesting its value in evaluating fibrotic bone lesions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Samadi MH, Sahafi P, Emadi Toghabeh A, et al. Fibrous Dysplasia With 99m Tc-FAPI Uptake in a Patient Under Long-term Antiresorptive Therapy. Clin Nucl Med. 2026. PMID: 42410757. doi:10.1097/RLU.0000000000006109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。